Clinical trial
Indocyangreen Elimination in Cirrhosis and Acute Liver Failure
NCT00245310 · Heidelberg University, Other · Completed
Key facts
| NCT number | NCT00245310 |
|---|---|
| Title | Indocyangreen Elimination in Cirrhosis and Acute Liver Failure |
| Official title | Evaluation of the Indocyangreen Elimination as a Prognostic Marker in Decompensated Cirrhosis and Acute Liver Failure |
| Lead sponsor | Heidelberg University, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Acute Liver Failure, Liver Cirrhosis |
| Intervention type | Procedure |
| Interventions | Indocyangreen (ICG) clearance |
| Enrollment | 40 |
| Start date | Oct 1, 2005 |
| Primary completion | Oct 1, 2010 |
| Completion | Oct 1, 2010 |
| First posted | Oct 27, 2005 |
| Last update posted | Oct 11, 2010 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: